1-10 of 10
Nora Bayani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2198: The impact of carcinogens, obesity, and chronic inflammatory processes on mutational signatures and cancer risk in mouse tumor models

Free
Yun Rose Li, Kyle Halliwill, Eve Kandyba, Reyno Delrosario, Quan Tran, Nora Bayani, Di Wu, Olga Mirzoeva, Melissa McCreery Reeves, Mishu Islam, Laura Riva, Eric Bergstrom, John Digiovanni, Ludmil Alexandrov, Allan Balmain
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2198.
https://doi.org/10.1158/1538-7445.AM2022-2198
Published: 15 June 2022
View articletitled, Abstract 2198: The impact of carcinogens, obesity, and chronic inflammatory processes on mutational signatures and cancer risk in mouse tumor models
Journal Articles

Abstract 2387: Activation of Inhibin A signaling is associated with a basal-like HER2 subtype and resistance to lapatinib in breast cancer cell lines.

Free
James E. Korkola, Juha Rantala, Nora Bayani, Laura Heiser, Nicholas Wang, Obi Griffith, Joe Gray
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2387.
https://doi.org/10.1158/1538-7445.AM2013-2387
Published: 15 April 2013
View articletitled, Abstract 2387: Activation of Inhibin A signaling is associated with a basal-like HER2 subtype and resistance to lapatinib in breast cancer cell lines.
Journal Articles

Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines

Free
James Korkola, Nora Bayani, Brian Cooper, Laura M. Heiser, Paul T. Spellman, Heidi S. Feiler, Richard Wooster, Joe W. Gray
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 639.
https://doi.org/10.1158/1538-7445.AM2011-639
Published: 15 April 2011
View articletitled, Abstract 639: Inhibition of HER2 signaling using targeted therapeutics in breast cancer cell lines
Journal Articles

Abstract 49: Constructing pathway based predictors of cancer clinical outcome

Free
Sam Ng, Charlie Vaske, Steve Benz, James Durbin, Chris Szeto, Laura Heiser, Nicholas Wang, Jim Korkola, Nora Bayani, Paul Spellman, Joe W. Gray, David Haussler, Joshua Stuart
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 49.
https://doi.org/10.1158/1538-7445.AM2011-49
Published: 15 April 2011
View articletitled, Abstract 49: Constructing pathway based predictors of cancer clinical outcome
Journal Articles

Abstract 1979: Algebraic factorization of gene expression profiles reveals subtype-specific drug sensitivities among 54 breast cancer cell lines

Free
William J. Gibb, Eric Collisson, James Korkola, Laura Heiser, Anguraj Sadanandam, Wen-Lin Kuo, Zhi Hu, Jian-Hua Mao, Nicholas Wang, Nora Bayani, Jessica Billig, Safiyyah Ziyad, Sophi Lewis, Heidi Feiler, Lakshmi Jakkula, Denise Wolf, Marc Lenburg, Paul Spellman, Joe Gray
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1979.
https://doi.org/10.1158/1538-7445.AM10-1979
Published: 15 April 2010
View articletitled, Abstract 1979: Algebraic factorization of gene expression profiles reveals subtype-specific drug sensitivities among 54 breast cancer cell lines
Journal Articles

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Free
Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser, Sanchita Bhattacharya, Doris Siwak, Rina Gendelman, Nora Bayani, Nicholas J. Wang, Richard M. Neve, Yinghui Guan, Zhi Hu, Zachary Knight, Heidi S. Feiler, Philippe Gascard, Bahram Parvin, Paul T. Spellman, Kevan M. Shokat, Andrew J. Wyrobek, Mina J. Bissell, Frank McCormick, Wen-Lin Kuo, Gordon B. Mills, Joe W. Gray, W. Michael Korn
Journal: Cancer Research
Cancer Res (2009) 69 (2): 565–572.
https://doi.org/10.1158/0008-5472.CAN-08-3389
Published: 15 January 2009
View articletitled, Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
Open the PDF for Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Systems-based analysis of responses to stimulation or inhibition of EGF receptor signaling in breast cancer cells

Free
Olga Mirzoeva, Jing Zhang, Richard Neve, Heidi Feiler, Ju Han, Wen-Lin Kuo, Nora Bayani, Zhi Hu, Yinhui Guan, Debopriya Das, Laura Heiser, Doris Siwak, Merrill Knapp, Gordon Mills, Keith Ladaroute, Carolyn Talcott, Bahram Parvin, Paul Spellman, Frank McCormick, Joe Gray, W. Korn
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4427.
Published: 01 May 2007
View articletitled, Systems-based analysis of responses to stimulation or inhibition of EGF receptor signaling in breast cancer cells
Journal Articles

ERK-pathway connectivity is dependent on tumor sub-type

Free
Sach Mukherjee, Nora Bayani, Naina Shastri, Kevin Hacker, Arunashree Bhamidipati, Erik Gentalen, Uyen Nguyen, David Voehringer, Karl Voss, Tom Yang, Peter Vander Horn, Steven Pelech, Terry Speed, Joe Gray, Richard Neve
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-255.
Published: 01 May 2007
View articletitled, ERK-pathway connectivity is dependent on tumor sub-type
Journal Articles

An adaptive approach to predicting chemosensitivity of tissue-specific cancer cells

Free
Debopriya Das, Wen-Lin Kuo, Yinghui Guan, Zhi Hu, Nick Wang, Nora Bayani, Heidi Feiler, Paul Spellman, Richard Neve, Joe Gray
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-254.
Published: 01 May 2007
View articletitled, An adaptive approach to predicting chemosensitivity of tissue-specific cancer cells
Journal Articles

A system to identify and validate baseline and biologic response predictors in breast cancer

Free
Richard M. Neve, Koei Chin, Sandy Devries, Jennifer Yeh, Jean-Philippe Coppe, Jane Fridyland, Laura Clark, Nora Bayani, Frances Tong, Terry Speed, Joe W. Gray
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 793.
Published: 15 April 2006
View articletitled, A system to identify and validate baseline and biologic response predictors in breast cancer